Bull
$244.27
Szenariopreis
$171.660
-0.910 (-0.53%)Zum Schluss
Universal Health Services, Inc. is a holding company. The Company operates, through its subsidiaries, including its management company, UHS of Delaware, Inc. It is engaged in owning and operating acute care hospitals and outpatient facilities, and behavioral healthcare facilities. Its segments include Acute Care Hospital Services and Behavioral Health Care Services. It owns and operates approximately 375 inpatient facilities and 168 outpatient and other facilities located in 40 states, Washington, D.C., the United Kingdom and Puerto Rico. It provides services, which include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. It also provides capital resources as well as a variety of management services to our facilities, including central purchasing, information services, finance and control systems, among others.
Universal Health Services Inc is currently priced at $171.66, which is below several analyst price targets, including $183 from RBC Capital and $190 from Goldman Sachs. However, the stock has shown a year-to-date decline of 21.93%, indicating significant downward pressure. The RSI is at 42.32, suggesting that the stock is nearing oversold territory, but it has not yet reached that threshold. The main risk is the recent downgrade by RBC Capital due to adverse items impacting earnings, which could affect future performance. Given these factors, it may be prudent to hold rather than buy at this time.
BofA
$170
2026-08-10
BofA
2026-08-10
Kursziel
$170
RBC Capital
$183
2026-08-03
RBC Capital
2026-08-03
Kursziel
$183
Goldman Sachs
$190
2026-07-30
Goldman Sachs
2026-07-30
Kursziel
$190
Guggenheim
$189
2026-07-29
Guggenheim
2026-07-29
Kursziel
$189
UBS
$290
2026-07-29
UBS
2026-07-29
Kursziel
$290
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

IMAX Stock Hits Record High Amid Unsuccessful Acquisition Talks

Universal Health Services to Present at Upcoming Conferences

Universal Health Services to Present at Upcoming Conferences

Hollywood's Return to the Chinese Market

IMAX Hits All-Time High Thanks to 'The Odyssey' Box Office Success
Universal Health Services, Inc. is a holding company. The Company operates, through its subsidiaries, including its management company, UHS of Delaware, Inc. It is engaged in owning and operating acute care hospitals and outpatient facilities, and behavioral healthcare facilities. Its segments include Acute Care Hospital Services and Behavioral Health Care Services. It owns and operates approximately 375 inpatient facilities and 168 outpatient and other facilities located in 40 states, Washington, D.C., the United Kingdom and Puerto Rico. It provides services, which include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. It also provides capital resources as well as a variety of management services to our facilities, including central purchasing, information services, finance and control systems, among others. It operates in the Healthcare sector (SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC industry).
Universal Health Services Inc is currently priced at $171.66, which is below several analyst price targets, including $183 from RBC Capital and $190 from Goldman Sachs. However, the stock has shown a year-to-date decline of 21.93%, indicating significant downward pressure. The RSI is at 42.32, suggesting that the stock is nearing oversold territory, but it has not yet reached that threshold. The main risk is the recent downgrade by RBC Capital due to adverse items impacting earnings, which could affect future performance. Given these factors, it may be prudent to hold rather than buy at this time.
16 analysts cover UHS: 11 rate it Buy, 5 Hold and 0 Sell. The average price target is 248.00.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.